FTC Challenges Accuracy of 100 Patents Held by 10 Large Drugmakers

Ten major pharmaceutical companies will be receiving letters from the FTC challenging the accuracy or proper listing of more than 100 patents listed in the FDA’s Orange Book, which catalogs approved drugs with therapeutic equivalence evaluations.
Source: Drug Industry Daily